60 likes | 263 Views
Most graphene producers currently produce graphene nanoplatelets and graphene oxide. Within the last year graphene producers have increased production capabilities considerably. XG Sciences, Angstron Materials and Vorbeck have increased, or are planning to increase, their production capacities twenty-fold.
E N D
Research on Global & China Graphene Industry, 2015 Single User License: US$ 1700 No of Pages: 86 Corporate User License: US$ 2750 www.rnrmarketresearch.com WEBSITE
Research on China Heparin Industry, 2015 In-depth analysis of Graphene Industry in Global & China, 2015 Report. Currently graphene is still in the research stage. The limitations of preparative technique and the inactive downstream demand determined that the graphene has yet to achieve large-scale mass production. In 2014, electronics, optoelectronics and data storage accounts for nearly 31% of global gaphene demand, composites ranks behind with a share of nearly 24%. ViewComplete Report @ http://www.rnrmarketresearch.com/research-on-global-china-graphene-industry-2015-market-report.html
Research on China Heparin Industry, 2015 The market size of China’s graphene market is about 29 million RMB, and could achieve a CAGR of 95% from 2014 to 2020. The driving forces mainly comes from composites and touch screen market. In 2014, graphene composites markets in China achieves 4.77 million RMB sales, accounting for 16.4% of total graphene sales in China. Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392988
Research on China Heparin Industry, 2015 In May 2015, Qianhong Bio-Pharma received the approval letter of enoxaparin sodium API and injection from CFDA. This made Qianhong the 5th enterprises for producing enoxaparin sodium in domestic market. (Time to volume production is still uncertain). In 2014, GSK, Changshan Biochemical Pharmaceutical and Hefei Zhaoke were top3 enterprises in the domestic low molecular heparin calcium market, with total market share of 88.7% in 2014. GSK is the leading enterprises in this segment for a long time, but its growth has slowed down in recent 2 to 3 years. Changshan’s product achieved rapid development relying on independent pricing, which is gradually becoming the import substitution product. In May 2015, Qianhong Bio-Pharma received the approval letter of enoxaparin sodium API and injection from CFDA. This made Qianhong the 5th enterprises for producing enoxaparin sodium in domestic market. (Time to volume production is still uncertain). Access Report by Chisult Insight at http://www.rnrmarketresearch.com/publisher/Chisult-Insight.html
Research on China Heparin Industry, 2015 Data Charts Hierarchical Structure of GrapheneProperties & Applications of GrapheneSketch map of wireless transmission ballistic transistorConductivity of Major Conductors(S/m)Carrier Mobility of Major Semiconductors(cm2/V•s)Enhanced Effect Comparison of Nano-fillerThermal Conductivity of Major Heat Sink materialsGraphene Absorbing BTEXFour PreparationTechnologies of GrapheneEach application requires a specific type and grade of graphene2013-2014 Graphite Output and Reserves Worldwide by CountriesMajor Graphene Device Processors WorldwideRead moreInquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=392988
RnR Market ResearchRnRMarketResearch.com, An online repository of market research reports, offers in-depth analysis of over 5000 market segments. RNR market research library has syndicated reports by leading market research publishers across the globe. For more details contact :sales@rnrmarketresearch.Com/ +18883915441FOLLOW US Website www.rnrmarketresearch.com